A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma: Report to the Medical Research Council by the Brain Tumor Working Party
Authors:
- 30 April 1989
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 16 (4) , 1077-1081
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Misonidazole and CCNU chemotherapy for recurrent primary brain tumorJournal of Neuro-Oncology, 1987
- A phase II study of CCNU with benznidazole for metastatic malignant melanomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986
- Phase II trial of misonidazole (MISO) and cyclophosphamide (CYC) in metastatic renal cell carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986
- Benznidazole with CCNU: A clinical phase i toxicity studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985
- A simplified assay for O6-methylguanine-DNA methyltransferase activity and its application to human neoplastic and non-neoplastic tissuesCarcinogenesis, 1984
- Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gainBritish Journal of Cancer, 1982
- The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazolesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- Chemical properties of nitrosoureas: Implications for interaction with misonidazoleInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cellsNature, 1980
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977